Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 5.62 Billion | USD 10.69 Billion | 7.4% | 2023 |
According to the report published by Zion Market Research, the global Pharmaceutical Gelatin Market size was valued at USD 5.62 Billion in 2023 and is predicted to reach USD 10.69 Billion by the end of 2032. The market is expected to grow with a CAGR of 7.4% during the forecast period. The report analyzes the global Pharmaceutical Gelatin Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Pharmaceutical Gelati industry.
By partial hydrolysis of collagen derived from the skins, hides, and bones of the animals, a soluble protein called gelatin is obtained. And gelatin to be considered as pharma-medical grade it has to meet certain standards. Pharmaceutical gelatin provides manufacturers of supplements and drugs a versatile excipient which is been widely used in the pharmaceutical industry for decades. Pharmaceutical gelatin is used in numerous pharmaceutical applications such as the production of softgels, hard capsules, tablets, as a stabilizer in vaccines, and many more.
The global pharmaceutical gelatin market is growing at a lucrative rate. Factors that are fueling the growth of the global market include expanding use of gelatin in medical & biomedical applications, growing demand for regenerative medicines, and growing preference of the consumer towards soft gelatin capsules as they are neutral in taste & easy to swallow. Further, for a wide range of therapeutic agents and medicines, gelatin capsules are considered to be a perfect delivery vehicle. Additionally, hydrolyzed gelatin is an important component of blood plasma substitute as it is highly compatible, is biodegradable, does not accumulate in the body, has a short retention time, and molecular behavior & viscosity are similar to blood plasma.
In some vaccines with low endotoxin levels, purified gelatin is used as a stabilizer and offers several benefits such helps to keep lyophilized products stable, ensures patient safety, and reduces the potential for side effects. In addition to this, natural origin, clean label-friendly, body temperature melting-point, biocompatibility, gel-strength, and thermo-reversible are some of the properties of the gelatin which makes it ideal for a wide range of applications in the pharmaceutical industry.
All these factors are spurring the growth of the global pharmaceutical gelatin market. Moreover, the increase in the use of fortified gummies as an alternative delivery system for minerals & vitamins not only for kids but also in the elderly population is also driving the overall market growth. Furthermore, technological advancements to reduce the amount of cross-linking of gelatin in the capsule and enhance its shelf life will have advantageous opportunities for the growth of the global pharmaceutical gelatin market over the forecast period. However, the elevated price of gelatin and easy availability of substitutes may hamper the growth of the global pharmaceutical gelatin market.
During the Covid-19 pandemic, a shortage of gelatin was experienced which affected the global pharmaceutical gelatin market. Drug manufacturers depend on animal sources for gelatin and due to lockdown and restriction on movements, travel curbs abattoirs, and cattle movement, a disruption in this cycle was observed. Additionally, the limitation on personnel movement and a temporary halt on manufacturing units also hampered the productivity of gelatin. Thus, the manufacturing value chain was been hampered in the pandemic period. However, with ease in restrictions and a boom in demand for gelatin in the pharmaceutical is expected to spur the growth of the global market during the forecast period.
The global pharmaceutical gelatin market is divided based on type, function, source, application, and region.
Based on type, the global pharmaceutical gelatin market is split into type A and type B.
The function segment, is bifurcated into gelling agents, thickening agents, stabilizing agents, and others.
Based on sources, Poultry, marine, bovine bone, bovine skin, and porcine are the sources of gelatin.
The application segment consists of absorbable hemostats, tablets, soft capsules, hard capsules, and others.
Report Attributes | Report Details |
---|---|
Report Name | Pharmaceutical Gelatin Market |
Market Size in 2023 | USD 5.62 Billion |
Market Forecast in 2032 | USD 10.69 Billion |
Growth Rate | CAGR of 7.4% |
Number of Pages | 201 |
Key Companies Covered | Darling Ingredients Inc., Gelco International, Xiamen Gelken Gelatin Co. Ltd., Italgelatine S.p.A, Lapi Gelatine S.p.A, Trobas Gelatine B.V., Weishardt, Gelita AG, Tessenderlo Group, and Nitta Gelatin Inc, and others |
Segments Covered | By type, By function, By source, By application and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America is estimated to hold the largest share in the global pharmaceutical gelatin market during the forecast period. Growing demand for soft gelatin capsules from the geriatric population, growing use of gelatin for stabilizing agents, and absorbable hemostats are boosting the growth of the market in this region. On the other hand, Asia Pacific is anticipated to grow at a faster rate and is expected to offer ample opportunities for market growth. Some of the factors that are propelling the growth of the market in this region include expanding pharmaceutical industries and the easy availability of gelatin sources.
some of the dominant players that are functioning in the global pharmaceutical gelatin market.
By Type
By function segment
By sources
By application segment
FrequentlyAsked Questions
Factors that are fueling the growth of the global market include expanding use of gelatin in medical & biomedical applications, growing demand for regenerative medicines, and growing preference of the consumer towards soft gelatin capsules as they are neutral in taste & easy to swallow. Furthermore, technological advancements to reduce the amount of cross-linking of gelatin in the capsule and enhance its shelf life will have advantageous opportunities for the growth of the global pharmaceutical gelatin market over the forecast period.
Darling Ingredients Inc., Gelco International, Xiamen Gelken Gelatin Co. Ltd., Italgelatine S.p.A, Lapi Gelatine S.p.A, Trobas Gelatine B.V., Weishardt, Gelita AG, Tessenderlo Group, and Nitta Gelatin Inc, and others are some of the dominant players that are functioning in the global pharmaceutical gelatin market.
North America is estimated to hold the largest share in the global pharmaceutical gelatin market during the forecast period. Growing demand for soft gelatin capsules from the geriatric population, growing use of gelatin for stabilizing agents and absorbable hemostats are boosting the growth of the market in this region.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed